News

IL-17E is a pro-inflammatory cytokine protein with a potential to stimulate immune response against cancer cells. Cancer Research UK’s Drug Development Office (DDO) will fund and carry out

As part of the alliance, the companies will employ their respective technologies to constitute diverse lantipeptide-based libraries. Under the alliance, MorphoSys will also license the LanthioPep technology for

Pursuant to the deal, Minapharm will leverage VTU´s Pichia pastoris protein expression technology in rHSA production and VTU will contribute expression strain development and bioprocess optimization process for

As per the deal, Parexel and NTUH will work together to offer drug development services required to advance clinical programs of biopharmaceutical firms in the region. Parexel International

OnBase, an enterprise content management solution, is used by healthcare organizations to complete patient records, eliminate reimbursement delays and enhance business processes. Stormont-Vail CIO Judy Corzine said using

Formulated as an iso-osmotic solution for intravitreal administration, the injection is a recombinant fusion protein comprising of portions of human VEGF receptors and extracellular domains fused to the

Placebo-controlled, parallel-group, multi-center trial will enroll around 400 patients to assess effects of AC-1204 on cognition, pharmacokinetic measures, daily living activities, resource utilization and quality of life among

Clindamycin Palmitate Hydrochloride used to treat infections caused by bacteria, is a FDA approved generic version of Pfizer’s Cleocin Pediatric. According to IMS Health data, Clindamycin Palmitate Hydrochloride

The upgraded facility includes two class 10,000 clean room facilities containing class 100 clean operation areas for open procedures, one for AlloStim and the other for AlloVax. The